Stereotactic radiosurgery for large brain metastases

Progress in Neurological Surgery

Volumn 25, Issue , 2012, Pages 248-260

  Han, Jung Ho ^a,c   Kim, Dong Gyu ^b,c   Kim, Chae Yong ^a,c   Chung, Hyun Tai ^b,c   Jung, Hee Won ^b,c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NEUROSURGERY; PATHOLOGY; RADIATION DOSE; RADIATION INJURY; RADIOSURGERY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSURGERY; RADIATION DOSAGE; RADIATION INJURIES; RADIOSURGERY;

EID: 84860801478     PISSN: 00796492     EISSN: 16623924     Source Type: Book Series    
DOI: 10.1159/000331198     Document Type: Article

References (43)

1. Karlsson B, et al: Thirty years' experience with Gamma Knife surgery for metastases to the brain. J Neurosurg 2009;111:449-457.
2. Da Silva AN, et al: Early brain tumor metastasis reduction following Gamma Knife surgery. J Neurosurg 2009;110:547-552.
3. Mariya Y, et al: Outcome of stereotactic radiosur-gery for patients with non-small cell lung cancer metastatic to the brain. J Radiat Res (Tokyo) 2010; 51:333-342.
4. Meisner J, et al: Outcome of moderately dosed radio-surgery for limited brain metastases: report of a single-center experience. Strahlenther Onkol 2010; 186:76-81.
5. Molenaar R, et al: Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 2009;23:170-178.
6. Yang HC, et al: What factors predict the response of larger brain metastases to radiosurgery? Neuro-surgery 2011;68:682-690.
7. Barker FG 2nd: Surgical and radiosurgical management of brain metastases. Surg Clin North Am 2005;85:329-345.
8. Patchell RA, et al: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
9. Weil RJ, Lonser RR: Selective excision of metastatic brain tumors originating in the motor cortex with preservation of function. J Clin Oncol 2005;23:1209-1217.
10. Mintz AH, et al: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;78:1470-1476.
11. Vecht CJ, et al: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583-590.
12. Paek SH, et al: Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005;56:1021-1034.
13. Yoo H, et al: Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 2009;110:730-736.
14. Stark AM, et al: Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005;28:115-119.
15. Sperduto P W, et al: A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008; 70:510-514.
16. Gaspar LE, et al: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000;47: 1001-1006.
17. Shuto T, et al: Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of Gamma Knife surgery or craniotomy for control of growth and peritumoral edema. J Neurooncol 2010; 98:169-175.
18. Wronski M, Arbit E: Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000;93:9-18.
19. Siomin VE, et al: Posterior fossa metastases: risk of leptomeningeal disease when treated with stereot-actic radiosurgery compared to surgery. J Neuro-oncol 2004;67:115-121.
20. Lassen B, et al: Surgical mortality at 30 days and complications leading to recraniotomy in 2,630 consecutive craniotomies for intracranial tumors. Neurosurgery, 2011.
21. Mintz A, et al: Management of single brain metastasis: a practice guideline. Curr Oncol 2007;14:131-143.
22. Suki D, et al: Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery 2009;64:664-674.
23. Mendez IM, Del Maestro RF: Cerebral metastases from malignant melanoma. Can J Neurol Sci 1988; 15:119-123.
24. Ernst-Stecken A, et al: Phase II trial of hypofrac-tionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 2006;81: 18-24.
25. Shiau C Y, et al: Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997;37: 375-383.
26. Kjellberg RN: Isoeffective dose parameters for brain necrosis in relation to proton radiosurgical dosime-try; in Szilka G (ed): Stereotactic Cerebral Irradiation. Proc INSERM Symp Stereotactic Irradiation Held, Paris, 1979. Amsterdam, Elsevier, 1979, pp 157-166.
27. Shaw E, et al: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47:291-298.
28. Kano H, et al: T1/T2 matching to differentiate tumor growth from radiation effects after stereotac-tic radiosurgery. Neurosurgery 2010;66:486-491.
29. Rutigliano MJ, et al: The cost effectiveness of ste-reotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 1995;37:445-453.
30. Cedzich C, et al: Somatosensory evoked potential phase reversal and direct motor cortex stimulation during surgery in and around the central region. Neurosurgery 1996;38:962-970.
31. Ebeling U, et al: Safe surgery of lesions near the motor cortex using intra-operative mapping techniques: a report on 50 patients. Acta Neurochir (Wien) 1992;119:23-28.
32. Tan TC, Mc LBP: Image-guided craniotomy for cerebral metastases: techniques and outcomes. Neurosurgery 2003;53:82-89.
33. Flickinger JC, Loeffler JS, Larson DA: Stereotactic radiosurgery for intracranial malignancies. Oncology (Williston Park) 1994;8:81-86.
34. Mehta MP, et al: Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 1992;24:619-625.
35. Shehata MK, et al: Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 2004;59:87-93.
36. Auchter RM, et al: A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996;35:27-35.
37. Serizawa T, et al: Gamma knife surgery for brain metastases: indications for and limitations of a local treatment protocol. Acta Neurochir (Wien) 2005; 147:721-726.
38. Aoyama H, et al: Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radio-surgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-2491.
39. Sahgal A, et al: Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010;78:605-608.
40. Schlienger M, et al: Hypofractionated stereotactic radiotherapy for brain metastases. Cancer Radiother 2010;14:119-127.
41. Aoki M, et al: Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three meta-static brain tumors, with noninvasive fixation of the skull without whole brain irradiation. Int J Radiat Oncol Biol Phys 2006;64:414-418.
42. Aoyama H, et al: Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 2003;56:793-800.
43. Ma L, et al: Equivalence in dose fall-off for isocen-tric and nonisocentric intracranial treatment modalities and its impact on dose fractionation schemes. Int J Radiat Oncol Biol Phys 2010;76:943-948.